NanoEcho’s Q2 report has now been published, and during the period several significant milestones have been achieved, strengthening the company’s position going forward. The first clinical study has been successfully completed, and alongside this, the first image of detected nanoparticles in a rectal lymph node has been published. The studies have also confirmed both the system’s user-friendliness and its health economic potential.
“It is not every day that a research project takes the step from the lab to clinical validation while also securing its first revenue prospects. But that is exactly where we are,” comments CEO Linda Persson.
📄 Read the full report here (in Swedish)
🎥 Watch CEO Linda Persson summarise the quarter below! (subtitled in English)
